CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

C$0.05
-0.01 (-9.09%)
(As of 09:33 AM ET)
Today's Range
C$0.05
C$0.05
50-Day Range
C$0.05
C$0.09
52-Week Range
C$0.04
C$0.09
Volume
9,500 shs
Average Volume
93,472 shs
Market Capitalization
C$6.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VM stock logo

About Voyageur Pharmaceuticals Stock (CVE:VM)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

VM Stock Price History

VM Stock News Headlines

Voyageur Pharmaceuticals Ltd VM
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Closing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
See More Headlines
Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-1,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$6.94 million
Optionable
Not Optionable
Beta
0.49
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Brent Willis Bsc.Eng (Age 53)
    President, CEO & Director
    Comp: $131k
  • Mr. Bradley Craig Willis P.Eng. (Age 53)
    Founder, COO & Director
    Comp: $125.5k
  • Mr. Albert Deslauriers
    Chief Financial Officer

VM Stock Analysis - Frequently Asked Questions

How have VM shares performed in 2024?

Voyageur Pharmaceuticals' stock was trading at C$0.08 on January 1st, 2024. Since then, VM stock has decreased by 33.3% and is now trading at C$0.05.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Voyageur Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS).

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:VM) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners